- Home
- GDL vs BDTX Comparison
GDL vs BDTX Comparison
Compare GDL & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDL
- BDTX
- Stock Information
- Founded
- GDL 2006
- BDTX 2014
- Country
- GDL United States
- BDTX United States
- Employees
- GDL N/A
- BDTX N/A
- Industry
- GDL Investment Managers
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GDL Finance
- BDTX Health Care
- Exchange
- GDL Nasdaq
- BDTX Nasdaq
- Market Cap
- GDL N/A
- BDTX 96.9M
- IPO Year
- GDL N/A
- BDTX 2020
- Fundamental
- Price
- GDL $8.23
- BDTX $1.57
- Analyst Decision
- GDL
- BDTX Strong Buy
- Analyst Count
- GDL 0
- BDTX 5
- Target Price
- GDL N/A
- BDTX $15.60
- AVG Volume (30 Days)
- GDL 11.2K
- BDTX 8.3M
- Earning Date
- GDL 01-01-0001
- BDTX 03-06-2025
- Dividend Yield
- GDL 6.02%
- BDTX N/A
- EPS Growth
- GDL N/A
- BDTX N/A
- EPS
- GDL N/A
- BDTX N/A
- Revenue
- GDL N/A
- BDTX N/A
- Revenue This Year
- GDL N/A
- BDTX N/A
- Revenue Next Year
- GDL N/A
- BDTX N/A
- P/E Ratio
- GDL N/A
- BDTX N/A
- Revenue Growth
- GDL N/A
- BDTX N/A
- 52 Week Low
- GDL $7.65
- BDTX $1.51
- 52 Week High
- GDL $8.13
- BDTX $7.66
- Technical
- Relative Strength Index (RSI)
- GDL 45.59
- BDTX 37.67
- Support Level
- GDL $8.32
- BDTX $1.55
- Resistance Level
- GDL $8.35
- BDTX $1.84
- Average True Range (ATR)
- GDL 0.07
- BDTX 0.22
- MACD
- GDL -0.01
- BDTX 0.00
- Stochastic Oscillator
- GDL 18.75
- BDTX 5.88
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.